Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Jason Karp Doubles His Stake In SunOpta Inc (USA) (STKL); Stockbridge Partners Ups Interest In Advanced Drainage Systems Inc (WMS)

Page 1 of 2

Jason Karp is bullish on SunOpta, Inc. (USA) (NASDAQ:STKL) having more than doubled his investment in the company, as reported in a recent filing with the Securities and Exchange Commission. Karp’s fund Tourbillon Capital Partners has disclosed ownership of 5.22 million shares, up from the 2.0 million shares reported in its latest 13F filing for the period of June 30. The current position gives Karp and Tourbillon control over 7.6% of SunOpta’s common stock. In another filing, Berkshire Partners’ subsidiary, Stockbridge Partners, managed by Robert J. Small, has reported the addition of approximately 800,000 shares of Advanced Drainage Systems Inc (NYSE:WMS) to its previous stake, taking it to 3.66 million shares or 6.9% of the company’s total number of shares outstanding.

Jason Karp - Tourbillon Capital Partners

Most investors don’t understand hedge funds and indicators that are based on hedge funds’ activities. They ignore hedge funds because of their recent poor performance in the bull market. Our research indicates that hedge funds underperformed because they aren’t 100% long. Hedge fund fees are also very large compared to the returns generated and they reduce the net returns experienced by investors. We uncovered that hedge funds’ long positions actually outperformed the market. For instance the 15 most popular small-cap stocks among funds beat the S&P 500 Index by more than 60 percentage points since the end of August 2012. These stocks returned a cumulative of 118% vs. less than a 58% gain for the S&P 500 Index (read the details). That’s why we believe investors should pay attention to what hedge funds are buying (rather than what their net returns are).

A former understudy of Steven Cohen, Jason Karp started his own fund, Tourbillon Capital Partners in 2013, with an initial injection of $250 million in capital. Since then, the fund has grown to manage an equity portfolio valued at $4.6 billion according to its latest 13F filing. Karp is betting big on consumer discretionary stocks, having invested nearly 40% of his funds in companies from this sector. He is also a fan of tech stocks, which represent several of his biggest bets. Karp’s top stock pick is Expedia Inc (NASDAQ:EXPE) with Tourbillon Capital holding 3.13 million shares valued at $342 million., Inc.(NASDAQ:AMZN) is also among his favorite tech stocks and his faith has been handsomely rewarded, as the online retail giant has surprised the market with great financial results this year. Tourbillon owns 375,000 shares, up by 3% during the second quarter, worth roughly $162 million.

Jason Karp
Jason Karp
Tourbillon Capital Partners

SunOpta, Inc. (USA) (NASDAQ:STKL) engages in the processing and marketing of natural, organic, and specialty food products and has spread its business operations across North America, Europe, and China. So far this year, the stock has fallen by approximately 25% up to yesterday’s closing price of $8.95 per share. SunOpta’s 2015 second quarter financial results fell short of Wall Street’s expectation, with the company posting revenues of $307 million and earnings per share of $0.05. In order to meet growing consumer demand, SunOpta, Inc. (USA) (NASDAQ:STKL) has continued investing in stand-up pouch packaging technology across several of its US-based facilities. According to Rik Jacobs, the company’s Chief Operating Office, “the enhanced technology and added capacity has led to new customers and expanding order volumes from existing customers.” Chuck Royce, the manager of Royce & Associates, is also a fan of SunOpta, having increased his exposure by 15% during the second quarter to some 3.15 million shares worth $33.8 million. Hedge fund guru Jim Simons, on the other hand, has dumped a third of his stake in the company, leaving his fund, Renaissance Technologies, with 157,700 shares valued at $1.69 million.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!